UHS has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
UHS has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.006 |
UHS's Cash to Debt is ranked lower than
94% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.32 vs. UHS: 0.006 ) |
UHS'
s 10-Year Cash to Debt Range
Min: 0.01 Max: 0.04 Current: 0.01 |
| Equity to Asset | -0.039 |
UHS's Equity to Asset is ranked lower than
99% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.26 vs. UHS: -0.039 ) |
UHS'
s 10-Year Equity to Asset Range
Min: -0.08 Max: 0.26 Current: -0.04 |
| Interest Coverage | 5.3 |
UHS's Interest Coverage is ranked lower than
61% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 7.80 vs. UHS: 5.3 ) |
UHS'
s 10-Year Interest Coverage Range
Min: 5 Max: 11 Current: 5.3 |
| F-Score: 5 |
|
| Z-Score: 1.88 |
|
| M-Score: -2.61 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 13.50 |
UHS's Operating margin (%) is ranked higher than
66% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 7.30 vs. UHS: 13.50 ) |
UHS'
s 10-Year Operating margin (%) Range
Min: 7.7 Max: 13.5 Current: 13.5 |
| Net-margin (%) | 6.4 |
UHS's Net-margin (%) is ranked higher than
55% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 3.85 vs. UHS: 6.4 ) |
UHS'
s 10-Year Net-margin (%) Range
Min: 3.5 Max: 6.4 Current: 6.4 |
| ROE (%) | 16.3 |
UHS's ROE (%) is ranked higher than
54% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 11.20 vs. UHS: 16.3 ) |
UHS'
s 10-Year ROE (%) Range
Min: 11.2 Max: 20 Current: 16.3 |
| ROA (%) | 5.4 |
UHS's ROA (%) is ranked lower than
56% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 4.60 vs. UHS: 5.4 ) |
UHS'
s 10-Year ROA (%) Range
Min: 3.1 Max: 8.4 Current: 5.4 |
| ROC (Joel Greenblatt) (%) | 24.30 |
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 17.40 vs. UHS: 24.30 ) |
UHS'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 13.6 Max: 24.3 Current: 24.3 |
| Revenue Growth (%) | 7.7 |
UHS's Revenue Growth (%) is ranked higher than
93% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 4.50 vs. UHS: 7.7 ) |
UHS'
s 10-Year Revenue Growth (%) Range
Min: 6.4 Max: 12.8 Current: 7.7 |
| EBITDA Growth (%) | 14.8 |
UHS's EBITDA Growth (%) is ranked higher than
95% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 4.70 vs. UHS: 14.8 ) |
UHS'
s 10-Year EBITDA Growth (%) Range
Min: 1.5 Max: 19.3 Current: 14.8 |
| EPS Growth (%) | 14.5 |
UHS's EPS Growth (%) is ranked higher than
91% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 7.70 vs. UHS: 14.5 ) |
UHS'
s 10-Year EPS Growth (%) Range
Min: -0.4 Max: 22.5 Current: 14.5 |
| Steven Cohen 153,588 sh (+252.04%) Joel Greenblatt 40,605 sh (+0.72%) Chris Davis 284,300 sh (+0.07%) | Vanguard Health Care Fund 4,120,800 sh (unchged) | Louis Moore Bacon Sold Out Private Capital 948,369 sh (-1.14%) Westport Asset Management 1,568,200 sh (-4.27%) Paul Tudor Jones 47,900 sh (-6.81%) Andreas Halvorsen 4,178,470 sh (-8.98%) Jim Simons 131,800 sh (-42.01%) |
| Jean-Marie Eveillard 898,114 sh (New) Manning & Napier Advisors, Inc 248,300 sh (New) Steven Cohen 335,135 sh (+118.2%) Joel Greenblatt 57,186 sh (+40.83%) | Chris Davis 284,300 sh (unchged) | Jim Simons Sold Out Paul Tudor Jones Sold Out Vanguard Health Care Fund 4,020,800 sh (-2.43%) Private Capital 887,219 sh (-6.45%) Westport Asset Management 1,324,213 sh (-15.56%) Andreas Halvorsen 2,975,594 sh (-28.79%) |
| Manning & Napier Advisors, Inc 2,591,290 sh (+943.61%) Steven Cohen 356,108 sh (+6.26%) Jean-Marie Eveillard 922,998 sh (+2.77%) | Westport Asset Management 1,174,213 sh (unchged) Vanguard Health Care Fund 4,020,800 sh (unchged) | Chris Davis 271,300 sh (-4.57%) Private Capital 801,341 sh (-9.68%) Joel Greenblatt 48,209 sh (-15.7%) Andreas Halvorsen 2,106,894 sh (-29.19%) |
| Ron Baron 200,790 sh (New) Andreas Halvorsen 2,625,972 sh (+24.64%) Joel Greenblatt 54,597 sh (+13.25%) | Westport Asset Management 1,165,268 sh (-0.76%) Vanguard Health Care Fund 3,873,600 sh (-3.66%) Chris Davis 251,300 sh (-7.37%) Private Capital 699,605 sh (-12.7%) Jean-Marie Eveillard 630,691 sh (-31.67%) Steven Cohen 223,995 sh (-37.1%) Manning & Napier Advisors, Inc 1,197,493 sh (-53.79%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Andreas Halvorsen | 2013-03-31 | Add 24.64% | 0.2% | $48.35 - $64.38 | $ 67.04 | 18% | 2625972 | |
| Ron Baron | 2013-03-31 | New Buy | 0.07% | $48.35 - $64.38 | $ 67.04 | 18% | 200790 | |
| Jean-Marie Eveillard | 2013-03-31 | Reduce -31.67% | 0.05% | $48.35 - $64.38 | $ 67.04 | 18% | 630691 | |
| Andreas Halvorsen | 2012-12-31 | Reduce -29.19% | 0.28% | $41.31 - $49.46 | $ 67.04 | 49% | 2106894 | |
| Andreas Halvorsen | 2012-09-30 | Reduce -28.79% | 0.43% | $38.17 - $45.75 | $ 67.04 | 63% | 2975594 | |
| Jean-Marie Eveillard | 2012-09-30 | New Buy | 0.15% | $38.17 - $45.75 | $ 67.04 | 63% | 898114 | |
| Joel Greenblatt | 2012-09-30 | Add 40.83% | 0.05% | $38.17 - $45.75 | $ 67.04 | 63% | 57186 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 15.10 |
UHS's P/E(ttm) is ranked higher than
80% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 16.20 vs. UHS: 15.10 ) |
UHS'
s 10-Year P/E(ttm) Range
Min: 8.02 Max: 37 Current: 15.1 |
| P/B | 2.40 |
UHS's P/B is ranked lower than
54% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.99 vs. UHS: 2.40 ) |
UHS'
s 10-Year P/B Range
Min: 1.01 Max: 5.24 Current: 2.4 |
| P/S | 0.90 |
UHS's P/S is ranked higher than
53% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.81 vs. UHS: 0.90 ) |
UHS'
s 10-Year P/S Range
Min: 0.33 Max: 1.61 Current: 0.9 |
| PFCF | 15.00 |
UHS's PFCF is ranked lower than
51% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 14.34 vs. UHS: 15.00 ) |
UHS'
s 10-Year PFCF Range
Min: 8.13 Max: 333.88 Current: 15 |
| EV-to-EBIT | 11.2 |
UHS's EV-to-EBIT is ranked higher than
95% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 13.20 vs. UHS: 11.2 ) |
UHS'
s 10-Year EV-to-EBIT Range
Min: 6.1 Max: 21.7 Current: 11.2 |
| PEG | 0.7 |
UHS's PEG is ranked higher than
97% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.30 vs. UHS: 0.7 ) |
UHS'
s 10-Year PEG Range
Min: 0.41 Max: 3.44 Current: 0.7 |
| Shiller P/E | 21.4 |
UHS's Shiller P/E is ranked higher than
78% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 11.50 vs. UHS: 21.4 ) |
UHS'
s 10-Year Shiller P/E Range
Min: 8.28 Max: 26.74 Current: 21.4 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 0.30 |
UHS's Dividend Yield is ranked higher than
60% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.85 vs. UHS: 0.30 ) |
UHS'
s 10-Year Dividend Yield Range
Min: 0.14 Max: 0.99 Current: 0.3 |
| Dividend Payout | 0.1 |
UHS's Dividend Payout is ranked higher than
99% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.75 vs. UHS: 0.1 ) |
UHS'
s 10-Year Dividend Payout Range
Min: 0.03 Max: 0.12 Current: 0.1 |
| Dividend growth (3y) | 8.4 |
UHS's Dividend growth (3y) is ranked higher than
93% of the 95 Companies in the Global Medical Care industry. ( Industry Median: -6.00 vs. UHS: 8.4 ) |
UHS'
s 10-Year Dividend growth (3y) Range
Min: 0 Max: 41.4 Current: 8.4 |
| Yield on cost (5-Year) | 0.44 |
UHS's Yield on cost (5-Year) is ranked higher than
59% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 2.00 vs. UHS: 0.44 ) |
UHS'
s 10-Year Yield on cost (5-Year) Range
Min: 0.21 Max: 1.45 Current: 0.44 |
| Share Buyback Rate | 0.1 |
UHS's Share Buyback Rate is ranked higher than
88% of the 95 Companies in the Global Medical Care industry. ( Industry Median: -0.60 vs. UHS: 0.1 ) |
UHS'
s 10-Year Share Buyback Rate Range
Min: 5.1 Max: -1.2 Current: 0.1 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 8.2 |
UHS's Price/Net Current Asset Value is ranked higher than
63% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 6.55 vs. UHS: 8.2 ) |
UHS'
s 10-Year Price/Net Current Asset Value Range
Min: 3.9 Max: 12.2 Current: 8.2 |
| Price/DCF (Projected) | 1.2 | ||
| Price/Median PS Value | 1.2 |
UHS's Price/Median PS Value is ranked higher than
57% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 0.90 vs. UHS: 1.2 ) |
UHS'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 2.1 Current: 1.2 |
| Price/Peter Lynch Fair Value | 0.7 |
UHS's Price/Peter Lynch Fair Value is ranked higher than
89% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 1.10 vs. UHS: 0.7 ) |
UHS'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.5 Max: 2.9 Current: 0.7 |
| Earnings Yield (Greenblatt) | 8.90 |
UHS's Earnings Yield (Greenblatt) is ranked lower than
78% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 8.50 vs. UHS: 8.90 ) |
UHS'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.6 Max: 16.5 Current: 8.9 |
| Forward Rate of Return (Yacktman) | 24.39 |
UHS's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 95 Companies in the Global Medical Care industry. ( Industry Median: 11.99 vs. UHS: 24.39 ) |
UHS'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 7.6 Max: 26.1 Current: 24.39 |
| Industry: | Medical Care | |
|---|---|---|
| Compare: | CHE, FMS, DVA, FSNUY, BDUUF | |
| Traded in other countries: | UHID.USA, UHS.Germany |
| Benzinga's Top Downgrades May 17 2013 - BENZINGA |